This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Oct;48(10):1577-9.

doi: 10.2967/jnumed.107.041947.

18F-DOPA PET and PET/CT

Cristina Nanni¹, Stefano Fanti, Domenico Rubello

Affiliations

PMID: 17909255
DOI: 10.2967/jnumed.107.041947

Free article

Comment

18F-DOPA PET and PET/CT

Cristina Nanni et al. J Nucl Med. 2007 Oct.

Free article

. 2007 Oct;48(10):1577-9.

doi: 10.2967/jnumed.107.041947.

Authors

Cristina Nanni¹, Stefano Fanti, Domenico Rubello

Affiliation

¹ S. Orsola-Malpighi Hospital, Bologna, Italy.

PMID: 17909255
DOI: 10.2967/jnumed.107.041947

No abstract available

PubMed Disclaimer

Comment on

The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.
Timmers HJ, Hadi M, Carrasquillo JA, Chen CC, Martiniova L, Whatley M, Ling A, Eisenhofer G, Adams KT, Pacak K. Timmers HJ, et al. J Nucl Med. 2007 Oct;48(10):1599-606. doi: 10.2967/jnumed.107.042721. Epub 2007 Sep 14. J Nucl Med. 2007. PMID: 17873132 Clinical Trial.

Similar articles

Current status and future challenges of brain imaging with (18)F-DOPA PET for movement disorders.
Calabria FF, Calabria E, Gangemi V, Cascini GL. Calabria FF, et al. Hell J Nucl Med. 2016 Jan-Apr;19(1):33-41. doi: 10.1967/s002449910335. Epub 2016 Mar 1. Hell J Nucl Med. 2016. PMID: 26929938 Review.
Advances in PET. Part I. Foreword.
Gross MD, Rubello D. Gross MD, et al. Q J Nucl Med Mol Imaging. 2007 Sep;51(3):213. Q J Nucl Med Mol Imaging. 2007. PMID: 17579572 No abstract available.
18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours.
Chondrogiannis S, Grassetto G, Marzola MC, Rampin L, Massaro A, Bellan E, Ferretti A, Mazza A, Al-Nahhas A, Rubello D. Chondrogiannis S, et al. Nucl Med Commun. 2012 Feb;33(2):179-84. doi: 10.1097/MNM.0b013e32834e0974. Nucl Med Commun. 2012. PMID: 22083098
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.
Ambrosini V, Tomassetti P, Rubello D, Campana D, Nanni C, Castellucci P, Farsad M, Montini G, Al-Nahhas A, Franchi R, Fanti S. Ambrosini V, et al. Nucl Med Commun. 2007 Jun;28(6):473-7. doi: 10.1097/MNM.0b013e328182d606. Nucl Med Commun. 2007. PMID: 17460538 Clinical Trial.
Recent advances in cardiac PET and PET/CT myocardial perfusion imaging.
Heller GV, Calnon D, Dorbala S. Heller GV, et al. J Nucl Cardiol. 2009 Nov-Dec;16(6):962-9. doi: 10.1007/s12350-009-9142-5. J Nucl Cardiol. 2009. PMID: 19756909 Review. No abstract available.

See all similar articles

Cited by

PET-specific parameters and radiotracers in theoretical tumour modelling.
Jennings M, Marcu LG, Bezak E. Jennings M, et al. Comput Math Methods Med. 2015;2015:415923. doi: 10.1155/2015/415923. Epub 2015 Feb 19. Comput Math Methods Med. 2015. PMID: 25788973 Free PMC article. Review.
Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component.
Veit-Haibach P, Schiesser M, Soyka J, Strobel K, Schaefer NG, Hesselmann R, Clavien PA, Hany TF. Veit-Haibach P, et al. Eur Radiol. 2011 Feb;21(2):256-64. doi: 10.1007/s00330-010-1930-4. Epub 2010 Aug 15. Eur Radiol. 2011. PMID: 20711731
Pharmacokinetic Modeling of ¹⁸F-FDOPA PET in the Human Brain for Early Parkinson's Disease.
Buratachwatanasiri W, Chantadisai M, Onwanna J, Chongpison Y, Rakvongthai Y, Khamwan K. Buratachwatanasiri W, et al. Mol Imaging Radionucl Ther. 2021 Jun 3;30(2):69-78. doi: 10.4274/mirt.galenos.2021.08831. Mol Imaging Radionucl Ther. 2021. PMID: 34082499 Free PMC article.
Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings.
Hou H, Wang C, Jia S, Hu S, Tian M. Hou H, et al. Neurosci Bull. 2014 Oct;30(5):765-76. doi: 10.1007/s12264-014-1469-5. Epub 2014 Sep 28. Neurosci Bull. 2014. PMID: 25260796 Free PMC article. Review.
Translational molecular imaging and drug development in Parkinson's disease.
Haider A, Elghazawy NH, Dawoud A, Gebhard C, Wichmann T, Sippl W, Hoener M, Arenas E, Liang SH. Haider A, et al. Mol Neurodegener. 2023 Feb 10;18(1):11. doi: 10.1186/s13024-023-00600-z. Mol Neurodegener. 2023. PMID: 36759912 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Medical